Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States

McNamara, Maeve; Furukawa, Nathan; Cartwright, Emily J.

doi:10.3201/eid3013.230859

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States

4 2024
By McNamara, Maeve ; Furukawa, Nathan ; Cartwright, Emily J.
http://dx.doi.org/10.3201/eid3013.230859
Source: Emerg Infect Dis. 2024; 30(Suppl 1):S80-S87

[PDF-1.81 MB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

McNamara, Maeve ; Furukawa, Nathan ; Cartwright, Emily J.

McNamara, Maeve ; Furukawa, Nathan ; Cartwright, Emily J. Less -
Description:

Incarcerated persons are infected with hepatitis C virus (HCV) at rates ≈10 times higher than that of the general population in the United States. To achieve national hepatitis C elimination goals, the diagnosis and treatment of hepatitis C in incarcerated persons must be prioritized. In 2022, the Centers for Disease Control and Prevention recommended that all persons receive opt-out HCV screening upon entry into a carceral setting. We review recommendations, treatments, and policy strategies used to promote HCV opt-out universal HCV screening and treatment in incarcerated populations in the United States. Treatment of hepatitis C in carceral settings has increased but varies by jurisdiction and is not sufficient to achieve HCV elimination. Strengthening universal HCV screening and treatment of HCV-infected incarcerated persons is necessary for HCV elimination nationwide.
Subjects:

[+]

Antiviral Agents Hepacivirus Hepatitis C Humans Mass Screening United States
Keywords:

[+]

Bacteria Burkholderia Pseudomallei Direct-acting Antivirals Hepatitis C Virus History Incarceration Melioidosis Opt-out Universal Screening Substance Use Treatment Viruses
Source:

Emerg Infect Dis. 2024; 30(Suppl 1):S80-S87
Pubmed ID:

38561831
Pubmed Central ID:

PMC10986823
Document Type:

Journal Article
Place as Subject:

United States
Volume:

30
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:a667ecf907896e7d24899956aae9424d3fe0abefdacf54178a53168197169617
Download URL:

https://stacks.cdc.gov/view/cdc/152943/cdc_152943_DS1.pdf
File Type:

	23-0859-F.gif	gif
	23-0859-F.jpg	jpeg
	23-0859.nxml	xml

More +